MUDr. Viliam Cibik, PhD., s.r.o.

Pruské 01852

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Clostridium Difficile Infection

Studies at this site

• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• Clostridium Difficile Vaccine Efficacy Trial — Completed